Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease

NCT07741045 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease (PD)
Parkinson Disease 6, Early-Onset

Interventions

DRUG: TJ0113 200mg
DRUG: TJ0113 400mg
DRUG: Placebo

Sponsor

Hangzhou PhecdaMed Co., Ltd.